Selegiline in Comparison with Methylphenidate in Treatment of Adults with Attention Deficit yperactivity Disorder: A Double-blind, Randomized Trial

 Objective: "n "nAttention-Deficit/Hyperactivity Disorder (ADHD) is one of the most common mental disorders in childhood and it continues to adulthood without proper treatment. Stimulants have been used in treatment of ADHD for many years and the efficacy of methylphenidate (MPH)...

Full description

Bibliographic Details
Main Authors: Farbod Fadai, Shahin Akhondzadeh, Mohammad Mohammadi, Mohammad Reza Mohammadi
Format: Article
Language:English
Published: Tehran University of Medical Sciences 2009-12-01
Series:Iranian Journal of Psychiatry
Subjects:
Online Access:http://journals.tums.ac.ir/PdfMed.aspx?pdf_med=/upload_files/pdf/15556.pdf&manuscript_id=15556
id doaj-0f14c916f4d74447aee1cf1514f15817
record_format Article
spelling doaj-0f14c916f4d74447aee1cf1514f158172020-11-24T23:11:31ZengTehran University of Medical SciencesIranian Journal of Psychiatry1735-45872008-22152009-12-0144126130Selegiline in Comparison with Methylphenidate in Treatment of Adults with Attention Deficit yperactivity Disorder: A Double-blind, Randomized TrialFarbod FadaiShahin AkhondzadehMohammad MohammadiMohammad Reza Mohammadi Objective: "n "nAttention-Deficit/Hyperactivity Disorder (ADHD) is one of the most common mental disorders in childhood and it continues to adulthood without proper treatment. Stimulants have been used in treatment of ADHD for many years and the efficacy of methylphenidate (MPH) in the treatment of adults with ADHD has been proven to be acceptable according to meta-analysis studies. However, there are some concerns about stimulants. Finding other effective medications for the treatment of adult ADHD seems necessary. We tried a monoamine oxidase inhibitor, Selegiline, as there are some theoretical and experimental evidences for the efficacy of this medication . "nMethod: Forty patients were randomized to receive Selegiline or methylphenidate in an equal ratio for an 8-week double-blind clinical trial. Each patient filled the CAARS self report screening form before starting to take the medication and in weeks 2-4-6 and 8. Patients were also assessed by a psychiatrist at the baseline and on each 14 days up to the 8 weeks period. "nResults: The mean score of the two groups- receiving Selegiline or methylphenidate- decreased over the 8 weeks. There was not a significant difference between the two groups. The most prevalent side-effect of methylphenidate was decrease of appetite and for Selegiline change in sleep pattern . "nConclusion: Selegiline is as effective as methylphenidate in the treatment of adults with Attention-Deficit/Hyperactivity Disorder. Selegiline can be an alternative medication for the treatment of adult ADHD If its clinical efficacy is proven by other larger studies . http://journals.tums.ac.ir/PdfMed.aspx?pdf_med=/upload_files/pdf/15556.pdf&manuscript_id=15556AdultAttention deficit disorder with hyperactivityMethylphenidateSelegiline
collection DOAJ
language English
format Article
sources DOAJ
author Farbod Fadai
Shahin Akhondzadeh
Mohammad Mohammadi
Mohammad Reza Mohammadi
spellingShingle Farbod Fadai
Shahin Akhondzadeh
Mohammad Mohammadi
Mohammad Reza Mohammadi
Selegiline in Comparison with Methylphenidate in Treatment of Adults with Attention Deficit yperactivity Disorder: A Double-blind, Randomized Trial
Iranian Journal of Psychiatry
Adult
Attention deficit disorder with hyperactivity
Methylphenidate
Selegiline
author_facet Farbod Fadai
Shahin Akhondzadeh
Mohammad Mohammadi
Mohammad Reza Mohammadi
author_sort Farbod Fadai
title Selegiline in Comparison with Methylphenidate in Treatment of Adults with Attention Deficit yperactivity Disorder: A Double-blind, Randomized Trial
title_short Selegiline in Comparison with Methylphenidate in Treatment of Adults with Attention Deficit yperactivity Disorder: A Double-blind, Randomized Trial
title_full Selegiline in Comparison with Methylphenidate in Treatment of Adults with Attention Deficit yperactivity Disorder: A Double-blind, Randomized Trial
title_fullStr Selegiline in Comparison with Methylphenidate in Treatment of Adults with Attention Deficit yperactivity Disorder: A Double-blind, Randomized Trial
title_full_unstemmed Selegiline in Comparison with Methylphenidate in Treatment of Adults with Attention Deficit yperactivity Disorder: A Double-blind, Randomized Trial
title_sort selegiline in comparison with methylphenidate in treatment of adults with attention deficit yperactivity disorder: a double-blind, randomized trial
publisher Tehran University of Medical Sciences
series Iranian Journal of Psychiatry
issn 1735-4587
2008-2215
publishDate 2009-12-01
description  Objective: "n "nAttention-Deficit/Hyperactivity Disorder (ADHD) is one of the most common mental disorders in childhood and it continues to adulthood without proper treatment. Stimulants have been used in treatment of ADHD for many years and the efficacy of methylphenidate (MPH) in the treatment of adults with ADHD has been proven to be acceptable according to meta-analysis studies. However, there are some concerns about stimulants. Finding other effective medications for the treatment of adult ADHD seems necessary. We tried a monoamine oxidase inhibitor, Selegiline, as there are some theoretical and experimental evidences for the efficacy of this medication . "nMethod: Forty patients were randomized to receive Selegiline or methylphenidate in an equal ratio for an 8-week double-blind clinical trial. Each patient filled the CAARS self report screening form before starting to take the medication and in weeks 2-4-6 and 8. Patients were also assessed by a psychiatrist at the baseline and on each 14 days up to the 8 weeks period. "nResults: The mean score of the two groups- receiving Selegiline or methylphenidate- decreased over the 8 weeks. There was not a significant difference between the two groups. The most prevalent side-effect of methylphenidate was decrease of appetite and for Selegiline change in sleep pattern . "nConclusion: Selegiline is as effective as methylphenidate in the treatment of adults with Attention-Deficit/Hyperactivity Disorder. Selegiline can be an alternative medication for the treatment of adult ADHD If its clinical efficacy is proven by other larger studies .
topic Adult
Attention deficit disorder with hyperactivity
Methylphenidate
Selegiline
url http://journals.tums.ac.ir/PdfMed.aspx?pdf_med=/upload_files/pdf/15556.pdf&manuscript_id=15556
work_keys_str_mv AT farbodfadai selegilineincomparisonwithmethylphenidateintreatmentofadultswithattentiondeficityperactivitydisorderadoubleblindrandomizedtrial
AT shahinakhondzadeh selegilineincomparisonwithmethylphenidateintreatmentofadultswithattentiondeficityperactivitydisorderadoubleblindrandomizedtrial
AT mohammadmohammadi selegilineincomparisonwithmethylphenidateintreatmentofadultswithattentiondeficityperactivitydisorderadoubleblindrandomizedtrial
AT mohammadrezamohammadi selegilineincomparisonwithmethylphenidateintreatmentofadultswithattentiondeficityperactivitydisorderadoubleblindrandomizedtrial
_version_ 1725603936874790912